Denali Advisors LLC Innoviva, Inc. Transaction History

Denali Advisors LLC

$846 Million
Q3 2025

A detailed history of Denali Advisors LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Denali Advisors LLC holds 77,200 shares of INVA stock, worth $1.72 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

77,200

Previous 332,661 76.79%

Holding current value

$1.72 Million

Previous $6.68 Million 78.93%

% of portfolio

0.17%

Previous 0.72%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$18.17 - $20.92 $4.64 Million - $5.34 Million	-255,461 Reduced 76.79%	77,200 $1.41 Million
Q2 2025 Jul 30, 2025	SELL	$17.1 - $21.8 $751,459 - $958,001	-43,945 Reduced 11.67%	332,661 $6.68 Million
Q1 2025 May 05, 2025	BUY	$17.21 - $18.98 $383,473 - $422,912	22,282 Added 6.29%	376,606 $6.83 Million
Q4 2024 Feb 04, 2025	SELL	$17.35 - $20.32 $452,453 - $529,904	-26,078 Reduced 6.86%	354,324 $6.15 Million
Q3 2024 Nov 13, 2024	SELL	$16.33 - $20.04 $969,740 - $1.19 Million	-59,384 Reduced 13.5%	380,402 $7.34 Million

Q2 2024 Aug 09, 2024	BUY	$14.4 - $16.4 $1.64 Million - $1.86 Million	113,700 Added 34.87%	439,786 $7.21 Million
Q1 2024 Apr 19, 2024	SELL	$14.56 - $16.78 $45,136 - $52,018	-3,100 Reduced 0.94%	326,086 $4.97 Million
Q4 2023 Jan 19, 2024	SELL	$12.32 - $16.27 $124,259 - $164,099	-10,086 Reduced 2.97%	329,186 $5.28 Million
Q3 2023 Oct 19, 2023	BUY	$12.37 - $13.89 $724,152 - $813,134	58,541 Added 20.85%	339,272 $4.41 Million
Q2 2023 Jul 18, 2023	SELL	$11.39 - $13.72 $756,296 - $911,008	-66,400 Reduced 19.13%	280,731 $3.57 Million
Q1 2023 Apr 21, 2023	BUY	$10.73 - $13.6 $301,201 - $381,765	28,071 Added 8.8%	347,131 $3.91 Million
Q4 2022 Feb 09, 2023	BUY	$11.8 - $13.78 $409,908 - $478,689	34,738 Added 12.22%	319,060 $4.23 Million
Q3 2022 Oct 25, 2022	BUY	$11.61 - $15.22 $124,227 - $162,854	10,700 Added 3.91%	284,322 $3.3 Million
Q2 2022 Jul 18, 2022	BUY	$14.32 - $19.88 $648,696 - $900,564	45,300 Added 19.84%	273,622 $4.04 Million
Q1 2022 Apr 19, 2022	SELL	$15.39 - $20.25 $320,112 - $421,200	-20,800 Reduced 8.35%	228,322 $4.42 Million
Q4 2021 Jan 21, 2022	SELL	$15.91 - $18.72 $428,742 - $504,466	-26,948 Reduced 9.76%	249,122 $4.3 Million
Q3 2021 Oct 12, 2021	SELL	$13.06 - $17.24 $1.41 Million - $1.87 Million	-108,200 Reduced 28.16%	276,070 $4.61 Million
Q1 2021 Apr 26, 2021	BUY	$11.06 - $12.87 $1.06 Million - $1.23 Million	95,740 Added 33.18%	384,270 $4.59 Million
Q4 2020 Jan 20, 2021	BUY	$9.33 - $12.48 $188,745 - $252,470	20,230 Added 7.54%	288,530 $3.58 Million
Q3 2020 Oct 16, 2020	BUY	$10.33 - $14.49 $1.06 Million - $1.49 Million	102,700 Added 62.02%	268,300 $2.8 Million
Q2 2020 Jul 23, 2020	BUY	$11.49 - $15.26 $1.9 Million - $2.53 Million	165,600 New	165,600 $2.32 Million
Q4 2017 Jan 24, 2018	SELL	$11.73 - $14.75 $473,892 - $595,900	-40,400 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$12.06 - $14.12 $487,224 - $570,448	40,400	40,400 $570,000

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Account

Denali Advisors LLC Innoviva, Inc. Transaction History